Discovery & Development

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.

Some scientists believe “dark” regions could be the key to understanding the relationship between our genetic makeup and diseases.

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally.

How fluid flow through the body can affect the ways in which antibiotics work.

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Experts explain why these are two important areas to watch in the near future of pharma R&D.

Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction.

Purdue University’s Young Institute is tackling pharma’s toughest challenges— from mRNA stability to aseptic manufacturing.

We get the story behind the development of Spiroligomer molecules and how they can help drug the undruggable.